The putative mechanisms of sarcopenia in patients with HCC are complex and are related to chronic inflammation, including tumor necrosis factor-α and interleukin-6, insulin resistance, and low levels of vitamin D, which lead to the progression of liver fibrosis and HCC [22,28,29,30]. This evidence concerns the gene IL6 and hepatocellular carcinoma.